Charming Medical Limited Notified of Anticipated Delisting from The Nasdaq Stock Market
Charming Medical securities may be eligible for over-the-counter trading following removal from Nasdaq.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nasdaq (NDAQ) notified Charming Medical (MCTA) that its securities will be delisted on November 9, 2026, unless Charming Medical appeals. An appeal would go to a Listing Qualifications Hearings Panel. The securities will remain halted and unavailable to trade until any appeal is resolved. Nasdaq determined that delisting is appropriate under its authority in IM-5101-4.
News Explained
The release adds a possible post-delisting venue: after removal from Nasdaq, Charming Medical's securities may be eligible for over-the-counter trading, though eligibility does not mean trading there will occur.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Charming Medical Limited (Nasdaq: MCTA) that its securities will be delisted from the Nasdaq Stock Market LLC on November 9, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.
Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf) Nasdaq halted trading in the Company’s ordinary shares on November 26, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.
For news and additional information about the company, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Charming Medical (MCTA) be delisted from Nasdaq?
Charming Medical securities will be delisted on November 9, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted and unavailable to trade until any appeal is resolved.